Download presentation
Presentation is loading. Please wait.
1
Volume 52, Issue 1, Pages 134-141 (July 2007)
Gemcitabine plus Cisplatin versus Gemcitabine plus Carboplatin as First-Line Chemotherapy in Advanced Transitional Cell Carcinoma of the Urothelium: Results of a Randomized Phase 2 Trial Luigi Dogliotti, Giacomo Cartenì, Salvatore Siena, Oscar Bertetto, Andrea Martoni, Aldo Bono, Dino Amadori, Haluk Onat, Luca Marini European Urology Volume 52, Issue 1, Pages (July 2007) DOI: /j.eururo Copyright © 2007 European Association of Urology Terms and Conditions
2
Fig. 1 Time to progressive disease for the gemcitabine–carboplatin (GC) arm and the gemcitabine–cisplatin (GP) arm. European Urology , DOI: ( /j.eururo ) Copyright © 2007 European Association of Urology Terms and Conditions
3
Fig. 2 Overall survival for the gemcitabine–carboplatin (GC) arm and the gemcitabine–cisplatin (GP) arm. European Urology , DOI: ( /j.eururo ) Copyright © 2007 European Association of Urology Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.